Genís - About the company
Genís is a series B company based in Akureyri (Iceland), founded in 2005. It operates as a Developer of therapeutics for inflammatory and degenerative conditions. Genís has raised $17M in funding. The company has 2772 active competitors, including 957 funded and 682 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences.
Company Details
Developer of therapeutics for inflammatory and degenerative conditions. It is currently working on the production of chitin, chitosan and chitin derived oligosaccharides for and leverage this research for developing drugs to treat a broad spectrum of inflammatory and degenerative conditions.
- Website
- www.genis.is/
- Email ID
- *****@genis.is
Key Metrics
Founded Year
2005
Location
Akureyri, Iceland
Stage
Series B
Total Funding
$17M in 6 rounds
Latest Funding Round
Ranked
933rd among 2772 active competitors
Employee Count
32 as on May 31, 2026
Sign up to download Genís' company profile
Genís's funding and investors
Genís has raised a total funding of $17M over 6 rounds. Its first funding round was on Jan 03, 2017. Its latest funding round was a Series B round on Dec 18, 2022 for $*****. 4 investors participated in its latest round. Genís has 5 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of Genís:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 18, 2022 | 6933744 | Series B | 6275816 | 4706775 | 5721943 | 6944696 |
Jul 31, 2020 | 2873501 | Grant (prize money) | 3066850 | 3034007 | 3108984 | |
Feb 01, 2018 | 1563837 | Grant (prize money) | 6554340 | 6005794 | 4657524 |
Access funding benchmarks and valuations. Sign up today!View details of Genís's funding rounds and investors
Genís' founders and board of directors
Founder? Claim ProfileGenís' employee count trend
Genís has 32 employees as of May 26. Here is Genís's employee count trend over the years:
Uncover Genís' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Genís's Competitors and alternates
Top competitors of Genís include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Here is the list of Top 10 competitors of Genís, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 82/100 | |
2nd |  Sana Biotechnology 2018, Seattle (United States), Public | Developer of engineered cell therapies for treating various human diseases | $821M | 75/100 | |
3rd | Ideaya Biosciences 2015, San Francisco (United States), Public | Developer of oncology-focused precision medicine using molecular diagnostics | $157M | 72/100 | |
4th | Sutro Biopharma 2003, United States, Public | Developer of antibody-based therapeutics for cancer therapy | $175M | 72/100 | |
5th | Syndax 2005, Waltham (United States), Public | Developer of targeted therapies for the treatment of cancer | $198M | 72/100 | |
6th | Karyopharm 2008, Newton (United States), Public | Biopharmaceutical company focused on developing and commercializing innovative cancer therapies | $98.4M | 71/100 | |
7th | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | 71/100 | |
8th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 71/100 | ||
9th | Developer of bi-specific antibodies & antibody-drug conjugates to treat cancer | $146M | 71/100 | ||
10th | _1545299782322.png?devicePixelRatio=2&height=30&width=30){kind=logo} Erasca 2018, San Diego (United States), Public | Developer of small molecule based therapeutics for cancer | $300M | 71/100 | |
933rd | Developer of therapeutics for inflammatory and degenerative conditions | $17M | 40/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Genís's competitors? Click here to see the top ones
Genís's Investments and acquisitions
Genís has made no investments or acquisitions yet.
News related to Genís
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Genís
Explore our recently published companies
- Saalfo Tech - Mysuru based, 1990 founded, Unfunded company
- Tolia - Thane based, 1979 founded, Unfunded company
- Uvtcpl - India based, Unfunded company
- Diamondexch99 - Unfunded company
- Krishna's Herbal & Ayurveda - Jodhpur based, 2007 founded, Funding Raised company
- Dash - Atlanta based, 2025 founded, Unfunded company
